, Public Policy Board), and he joined KDIGO volunteer leadership as an executive committee member in 2015 and has served as its Co-Chair since 2016. Consultancy: Akebia, Amgen, AstraZeneca, Bayer, Daiichi Sankyo, Relypsa, and Vifor Fresenius Medical Care Renal Pharma Methods Chair Marcello Tonelli, MD, SM, MSc, FRCPC, is senior associate dean (clinical research) at the Cumming School of Medicine in Calgary, Alberta, Canada. He is associate vice president (health research) at the University of Calgary. He received his medical degree from the University of Western Ontario, Canada, a Master of Science in epidemiology from Harvard University, Cambridge, MA, USA, and a Master of Science in health policy from Imperial College London, UK. He is a nephrologist and professor at the University of Calgary. Dr. Tonelli has served in the past as president of the Ca- nadian Society of Nephrology, councilor of the ISN, and a member of the KDIGO Executive Committee. Dr. Tonelli is Chair emeritus of the Canadian Task Force for Preventive Health Care, a national panel of experts that makes recom- mendations about preventive health services to Canada s 36,000 family physicians. A unique aspect of Dr. Tonelli s research program includes partnering with regional, provincial, and national decision makers to ensure that the ndings will be used to produce rational health policy. Speaker bureaus: B. Braun* *Monies donated to charity. Evidence Review Team Jonathan C. Craig, MBChB, DipCH, FRACP, M Med (Clin Epi), PhD, Evidence Review Team Director, is an interna- tionally recognized clinician and scientist and holds the position of vice president and executive dean of the College of Medicine & Public Health at Flinders Univer- sity, Adelaide, South Australia. 